MB Venture Partners
Gary Stevenson, Co-Founder and Managing Partner
Gary Stevenson co-founded MB Venture Partners in 2001 after six years in healthcare investment banking and equity research. At MBVP, he has raised $120 million in committed capital to four funds and invested in more than 50 start-ups, most of which are focused on product solutions for musculoskeletal disease. He also spent seven years in a variety of general management roles with Abbott Laboratories. Gary holds an undergraduate degree in accounting from the University of Missouri. He also received an MBA from the J.L. Kellogg Graduate School of Management at Northwestern University. He is a certified public accountant and a chartered financial analyst. Gary is a board member or observer for several MBVP portfolio companies. Medtronic, Smith + Nephew, Zimmer Biomet, and Wright Medical have each acquired MBVP-funded start-ups. This will be his 18th year to host the MNVC.
Charles Hamilton, Director, Healthcare Investment Banking
Charles Hamilton is a Director in the Piper Sandler healthcare investment banking group and a senior partner of the medical technology team. Hamilton has 20 years of healthcare investment banking and capital markets experience, and has completed over 75 M&A and capital markets transactions on behalf of his medical technology clients at Piper Sandler. Hamilton joined Piper Sandler in 2008 from Thomson Financial, where he was a senior investor relations consultant to publicly traded companies. Previously, Hamilton was a member of the Chicago Board of Trade and an open outcry market maker for commodities options contracts. Earlier in his career, he conducted research in gene therapies for vascular disease at The University of Chicago Hospitals Section of Vascular Surgery. Hamilton graduated from The University of Chicago with a bachelor’s degree in cell and molecular biology, and received a Master of Business Administration with concentrations in analytic finance and accounting from The University of Chicago Booth School of Business.
Patrick O’Donnell, President & CEO
Ian Helmar, Founder & V.P. of Research and Development
NanoHive Medical, LLC (formerly HD LifeSciences) is a pioneer and leading innovator in 3D printed spinal interbody fusion implants and instrumentation. The company’s proprietary, biomimetic Soft Titanium® technology clearly distinguishes their products in the $1.9B spinal interbody fusion device market. The Hive™ portfolio of interbody fusion devices provide surgeons and their patients ideal biomechanical elastic modulus properties, clear and precise diagnostic imaging capability, osteoblast cell attraction and integration – all features that lead to consistently strong fusion constructs and efficacious clinical experiences. NanoHive Medical is located in Woburn, Massachusetts U.S.A
Kevin Rocco, Founder and CEO
Jeff Baird, Chief Financial Officer
Biorez is a New Haven, CT-based medical device start-up focused on advancing the healing of soft tissues using its proprietary BioBrace technology. The company has pioneered the BioBrace implant, a breakthrough biocomposite scaffold featuring a highly porous collagen matrix that is reinforced with bioresorbable microfilaments. The BioBrace implant is intended to reinforce soft tissue repairs in several clinical applications and is cleared by the U.S. Food and Drug Administration under K203267.
Brian K. Hutchison, Chair and CEO
Ryan Bosco, Controller
Catalyst OrthoScience Inc., a medical device company focused on the upper extremity orthopedics market, is disrupting the usual approaches to shoulder replacement surgery. Catalyst’s ArcherTM CSR Total Shoulder System is a unique single-tray, bone-preserving arthroplasty system, offering precision and accuracy in shoulder restoration while preserving the patient’s bone and soft tissue. The ArcherTM R1 Reverse Shoulder System is a single-tray arthroplasty system that offers surgeon-targeted implant positioning, a streamlined and versatile system, and bone sparing implants. The company recently introduced its ArcherTM 3D Targeting imaging software for its current product offerings. Headquartered in Naples, Fla., Catalyst products are available across the U.S.
Ted Bird, Chief Strategy Officer
Jeff Bennett, President and COO
Dymicron is advancing a next generation total disc replacement system for the cervical spine – Triadyme-C™, made from polycrystalline diamond – one of the strongest substances known to man. Triadyme-C emulates the complex coupled motion of a natural spinal disc while providing stability throughout the range of motion. The exceptional durability of polycrystalline diamond virtually eliminates the risks of wear debris for the lifetime of the patient.